November 10, 2023 11:28 AM EST
R&D

Madri­gal’s got more pos­i­tive da­ta for resme­tirom, plus news from Ali­gos and North­Sea

Ayisha Sharma

News Reporter

The Amer­i­can As­so­ci­a­tion for the Study of Liv­er Dis­eases is set to hold its an­nu­al Liv­er Meet­ing this week­end in Boston. This morn­ing, we round­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times